What targeting eosinophils has taught us about their role in diseases
- 3 May 2010
- journal article
- review article
- Published by Elsevier in Journal of Allergy and Clinical Immunology
- Vol. 126 (1) , 16-25
- https://doi.org/10.1016/j.jaci.2010.02.026
Abstract
No abstract availableKeywords
This publication has 119 references indexed in Scilit:
- Organ-specific eosinophilic disorders of the skin, lung, and gastrointestinal tractJournal of Allergy and Clinical Immunology, 2010
- Eosinophils and allergic airway disease: there is more to the storyTrends in Immunology, 2010
- Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapyJournal of Allergy and Clinical Immunology, 2009
- Anti-Siglec-F antibody inhibits oral egg allergen induced intestinal eosinophilic inflammation in a mouse modelClinical Immunology, 2009
- Anti–IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levelsJournal of Allergy and Clinical Immunology, 2008
- Immunologic and inflammatory mechanisms that drive asthma progression to remodelingJournal of Allergy and Clinical Immunology, 2008
- Esophageal Remodeling Develops as a Consequence of Tissue Specific IL-5-Induced EosinophiliaGastroenterology, 2008
- Mechanisms of Eosinophilia in the Pathogenesis of Hypereosinophilic DisordersImmunology and Allergy Clinics of North America, 2007
- Chitin induces accumulation in tissue of innate immune cells associated with allergyNature, 2007
- A central regulatory role for eosinophils and the eotaxin/CCR3 axis in chronic experimental allergic airway inflammationProceedings of the National Academy of Sciences, 2006